TSC2 and cancer: Given the broad inhibitory action of 5-azacytidine on hypermethylation that leads to chromatin remodelling, as often occurs in several types of cancers, we have to consider that this drug might cause other demethylating effects besides the induction of tuberin expression, making this point a limitation of our study that could be overcome by the retroviral transduction of TSC2.